(Q36876695)

English

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial

scientific article published on 25 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial (English)

1 reference

Europe PubMed Central

16 August 2017

1 reference

based on heuristic

inferred from title

fluticasone furoate

1 reference

ChEBI release 2020-05-28

4

object named as

Jan Lötvall

0 references

Ashley Woodcock

object named as

Ashley Woodcock

5

0 references

object named as

Paul M O'Byrne

2

0 references

William W Busse

1

object named as

William W Busse

1 reference

Europe PubMed Central

16 August 2017

Eugene R Bleecker

3

object named as

Eugene R Bleecker

1 reference

Europe PubMed Central

16 August 2017

11

object named as

Eric D Bateman

1 reference

Europe PubMed Central

16 August 2017

Loretta Jacques

9

object named as

Loretta Jacques

1 reference

Europe PubMed Central

16 August 2017

author name string

Leslie Andersen

6

1 reference

Europe PubMed Central

16 August 2017

Wesley Hicks

7

1 reference

Europe PubMed Central

16 August 2017

Jodie Crawford

8

1 reference

Europe PubMed Central

16 August 2017

Ludovic Apoux

10

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

25 February 2013

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

68

1 reference

Europe PubMed Central

16 August 2017

513-520

1 reference

Europe PubMed Central

16 August 2017

6

1 reference

Europe PubMed Central

16 August 2017

Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

29 September 2017

Emerging therapeutic options for asthma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

29 September 2017

Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

29 September 2017

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

29 September 2017

Fluticasone at different doses for chronic asthma in adults and children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

29 September 2017

The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

29 September 2017

Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

29 September 2017

Efficacy and optimal dosing interval of the long-acting beta₂ agonist, vilanterol, in persistent asthma: a randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

4 September 2018

24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

4 September 2018

Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

4 September 2018

Oropharyngeal candidiasis with dry-powdered fluticasone propionate: 500 microg/day versus 200 microg/day

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664377

4 September 2018

Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202606

21 January 2018

Prevalence of potential noninvasive arrhythmia risk predictors in healthy, middle-aged persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/23440247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premature beats in healthy subjects 40-79 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/23440247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THORAXJNL-2012-202606

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36876695&oldid=2088056028"